TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03202524

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fresh Frozen Plasma (FFP)
Description: FFP will be used as a substitute for albumin for the prevention of post-paracentesis circulatory dysfunction.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Albumin
Description: Albumin will be used for the prevention of post-paracentesis circulatory dysfunction, as is the standard of care
Study: NCT02629354

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caffeine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Study: NCT02829294

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: E002 - cerumen removal aid
Description: topical treatment
Study: NCT02802774

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Plaster Splint
Description: The custom plaster splint is the historical standard. The surgical incision is dressed with non-stick gauze, 4x4 gauze pads, cotton padding, a plaster splint applied to the palmar surface of the palm and forearm, and then a cloth wrap to keep it all in place. Patients will wear the plaster splint for 2 weeks post-op.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Velcro Brace
Description: The Velcro wrist brace is a commercially available over-the-counter splint which will initially be fitted over a thin layer of non-stick gauze, 4x4 gauze, and cotton padding. Patients will be asked to wear the brace as much as possible for the first 2 weeks post-op.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Soft Dressing
Description: Patients in the soft dressing group will have non-stick gauze, 4X4 gauze, cotton padding, and a cloth wrap. It will be the same dressing as the custom splint without the plaster slab. Patients wear the soft dressing for the first three days post-op.
Study: NCT01324674

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bach´s Flower Remedy
Description: The subjects will have 4 drops 4 times per day, for approximately 8 months.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: The subjects will have a solution non-drug type, 4 drops 4 times per day, for approximately 8 months
Study: NCT00682682

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality video distraction
Description: Virtual Reality involves wearing a helmet and playing a game called Snow world. This game has sound and is presented in 3D format. This game has immersive qualities that help user feel as if they are in the game.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality video game
Description: Virtual Reality video games involve wearing a helmet with vision and sound. this game is presented in 3D which gives the user the feeling of being in the game. The game used for this study is Snow World
Study: NCT02640053

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Description: Applied topically

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT03429517

Intervention type: DIAGNOSTIC_TEST
Intervention: Lipogram
Description: liporgram samples

Intervention type: DIAGNOSTIC_TEST
Intervention: Lipogram
Description: liporgram samples
Study: NCT04105426

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Antioxidants
Description: one multivitamin and multimineral tablet with 500 mg grape seed extract once a day and one tablet of alpha-lipoic acid (300 mg ALA) twice a day for 3 months.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: one placebo tablet three times per day for 3 months.
Study: NCT04912193

Intervention type: DRUG
Intervention: Antithrombin III
Description: In liver transplant recipients with baseline antithrombin III levels lower than 50%, exogenous Antithrombin III was administrated during the anhepatic phase of the liver transplant surgery.
Study: NCT04289675

Intervention type: DRUG
Intervention: Interferon-Beta
Description: Theses drugs have been administered as part of routine care. Biological samples that will be analyzed (blood and cerebrospinal fluid) have been taken as part of routine care.
Study: NCT03520296

Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire evaluating well-being in relation to diet and nutrition

Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire evaluating well-being in relation to diet and nutrition
Study: NCT04607954

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Given IV
Study: NCT04723498

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: screening questionnaire
Description: Fill in screening questionnaire
Study: NCT04607954

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurbinectedin
Description: Given IV
Study: NCT01796561

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Olive leaf extract liquid
Description: Commercially available polyphenol-rich olive leaf extract liquid
Study: NCT00329238

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran
Description: Dabigatran 150 mg BID (twice daily)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin
Description: Warfarin dosed individually to maintain INR 2.0-3.0
Study: NCT00160290

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactulose
Description: 15 mL / 12 hours

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Plantago ovata
Description: 3,5 g / 12 hours
Study: NCT02528929

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Gluten-free diet
Description: Patients with IBS-D will commence a gluten-free diet for 6 weeks following dietetic input. They will be informed they do not have coeliac disease. They will however be blinded to whether or not they have any markers of at-risk serology. They will self-complete validated questionnaires over 6 weeks. Any subjects who opt to continue with a gluten-free diet thereafter of their own volition will be kept under observation as per routine clinical care.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Gluten-free diet
Description: Patients with IBS-D will commence a gluten-free diet for 6 weeks following dietetic input. They will be informed they do not have coeliac disease. They will however be blinded to whether or not they have any markers of at-risk serology. They will self-complete validated questionnaires over 6 weeks. Any subjects who opt to continue with a gluten-free diet thereafter of their own volition will be kept under observation as per routine clinical care.
Study: NCT02358174

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hemorrhoidectomy
Description: Grade III and IV patients were treated with surgery according to Milligan-Morgan (Milligan-Morgan laser optical fibers variant) procedure.~All patients will perform blood sampling for MMPs and NGAL plasma levels evaluation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood sampling
Description: blood sampling for MMPs and NGAL plasma levels evaluation (ELISA test)
Study: NCT05148936

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COVID-19 Testing Home-based (Aim 1)
Description: Implementation of Antigen and PCR testing at participant homes
Study: NCT02358174

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood sampling
Description: blood sampling for MMPs and NGAL plasma levels evaluation (ELISA test)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tissue sampling
Description: tissue sampling for MMPs and NGAL tissue levels evaluation (Western Blot)
Study: NCT05975892

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Transplantation of allogeneic MSCs in periodontal disease
Description: Oral surgery is performed in patients with periodontal disease, under local anesthesia. An incision will be made on the periodontal lesion, A full-thickness flap is elevated on both the buccal and lingual areas and the inner epithelium of the flap removed. Granulation tissue is removed from bone defect area, and a root planning is performed. MSC construct is placed around the bone defect and a collagen membrane is used to cover and close off the bone defect site. The flap will be repositioned and the wound closed by a suture
Study: NCT04505462

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic diet
Description: A special healthy diet for dialysis patients
Study: NCT03282682

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Strength training
Description: The participants perform strength training sessions two times per week for 12 weeks. Each training session include 5-minute general dynamic warm-up followed by progressive strength training with exercises for the entire body. The strength exercises are performed with free weights and on machines. The training program consist of 6 exercises for upper and lower body at an intensity of 60-80% (8 - 12RM: the load that induces technique failure in eight or twelve repetitions) of one-repetition maximum and takes approximately 60 minutes. The exercises performed are: leg press, split squats, bench press, knee extension, knee flexion, seated cable rows, seated cable pull downs, dumbbell bench press, incline dumbbell bench press.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Strength training
Description: The participants perform strength training sessions two times per week for 12 weeks. Each training session include 5-minute general dynamic warm-up followed by progressive strength training with exercises for the entire body. The strength exercises are performed with free weights and on machines. The training program consist of 6 exercises for upper and lower body at an intensity of 60-80% (8 - 12RM: the load that induces technique failure in eight or twelve repetitions) of one-repetition maximum and takes approximately 60 minutes. The exercises performed are: leg press, split squats, bench press, knee extension, knee flexion, seated cable rows, seated cable pull downs, dumbbell bench press, incline dumbbell bench press.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Strength training
Description: The participants perform strength training sessions two times per week for 12 weeks. Each training session include 5-minute general dynamic warm-up followed by progressive strength training with exercises for the entire body. The strength exercises are performed with free weights and on machines. The training program consist of 6 exercises for upper and lower body at an intensity of 60-80% (8 - 12RM: the load that induces technique failure in eight or twelve repetitions) of one-repetition maximum and takes approximately 60 minutes. The exercises performed are: leg press, split squats, bench press, knee extension, knee flexion, seated cable rows, seated cable pull downs, dumbbell bench press, incline dumbbell bench press.
Study: NCT06185283

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: panoramic x-ray
Description: Long cone paralleling technique and a film holder designed specifically for implant imaging were used for intraoral radiograph. To maintain the same film- implant distance and cone implant distance, a modification were carried out for the film holder. This modification is a hole drilled exactly above the implant fixture so the distance were maintained during subsequent film exposures. Through this modification, standardized radiographs were achieved.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: panoramic x-ray
Description: Long cone paralleling technique and a film holder designed specifically for implant imaging were used for intraoral radiograph. To maintain the same film- implant distance and cone implant distance, a modification were carried out for the film holder. This modification is a hole drilled exactly above the implant fixture so the distance were maintained during subsequent film exposures. Through this modification, standardized radiographs were achieved.
Study: NCT02981420

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safety planning
Description: Safety Planning Intervention. This brief one-session intervention, based on cognitive behavioral principles, is designed to help individuals identify a concrete list of coping strategies and social supports that youth can utilize preceding or during a crisis to lower imminent risk of suicidal behavior. In youth who also report nonsuicidal self-injurious behavior (NSSI), the safety plan will address both suicidal and nonsuicidal behavior. The plan helps youth identify possible triggers to SI/crisis including self-monitoring of suicidal thoughts, feelings, and behaviors; advance planning to remove lethal means; determine distress tolerance/emotion regulation skills that may be helpful; identify accessible social supports to target hopelessness/sense of isolation; reinforce the commitment to seek treatment; and, how and where to access emergency care.
Study: NCT02973698

Intervention type: OTHER
Group type: OTHER
Intervention: chin-down posture maneuver
Description: it was performed the training of Chin-down postural maneuver with saliva and water. Besides, the subjects received instructions regarding feeding.

Intervention type: OTHER
Group type: OTHER
Intervention: Orientations about swallowing
Description: The instructions about feeding were performed. The individuals received all the instructions on a written document.

Intervention type: OTHER
Group type: OTHER
Intervention: Orientations about swallowing
Description: The instructions about feeding were performed. The individuals received all the instructions on a written document.
Study: NCT05148936

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Testing Mobile (Aim 1)
Description: Implementation of Antigen and PCR testing at mobile test sites
Study: NCT02973698

Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: No intervention will do
Study: NCT05129215

Intervention type: OTHER
Intervention: Questionnaire
Description: The LARS score is used for assessment of bowel dysfunction after rectal cancer resection.

Intervention type: OTHER
Intervention: Questionnaire
Description: The LARS score is used for assessment of bowel dysfunction after rectal cancer resection.

Intervention type: OTHER
Intervention: Questionnaire
Description: The LARS score is used for assessment of bowel dysfunction after rectal cancer resection.
Study: NCT02478775

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Degarelix (GnRH antagonist)
Description: Day-1: Blood samples will be obtained every 10 minutes for 10 hours. After 10 hours of blood samples have been collected, the GnRH antagonist degarelix will be given subcutaneously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant FSH
Description: Day-2: Blood samples will again be obtained every 10 minutes for 10 hours. Repeated boluses of exogenous recombinant FSH (rFSH) will be given by IV during this 10 hour visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant FSH
Description: Day-2: Blood samples will again be obtained every 10 minutes for 10 hours. Repeated boluses of exogenous recombinant FSH (rFSH) will be given by IV during this 10 hour visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetrorelix
Description: Day-1: Blood samples will be obtained every 10 minutes for 10 hours. After 10 hours of blood samples have been collected, the GnRH antagonist Cetrorelix will be given subcutaneously.
Study: NCT04063930

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LOKELMA 5 GM Powder for Oral Suspension
Description: Sodium zirconium cyclosilicate (a hyperkalemia treatment)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Matching placebo
Study: NCT02217267

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: Lidocaine 3 mg/kg dilute in Normal Saline to 50 ml intravenous infusion in 1 hour

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01965301

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BP1.5375 suspension
Description: single oral dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BP1.5375 suspension
Description: single oral dose

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BP1.5375 suspension
Description: single oral dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Description: single oral dose of Diphenhydramine 50mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diphenhydramine
Description: single oral dose of Diphenhydramine 50mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Diphenhydramine
Description: single oral dose of Diphenhydramine 50mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single oral dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Single oral dose

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single oral dose
Study: NCT04306978

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CareLink Express RM system
Description: CareLink Express remote monitoring system consists of implantable pacemaker CareLink Express station for implanted Medtronic cardiac devices and provides remote data transmissions

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard follow-up
Description: Follow-up will be provided according to the standard guidelines (HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations; 2008)
Study: NCT05148936

Intervention type: OTHER
Group type: OTHER
Intervention: COVID-19 Testing Mobile Approach 1 (Aim 2)
Description: Implementation of Antigen and PCR testing at mobile test sites - active outreach

Intervention type: OTHER
Group type: OTHER
Intervention: COVID-19 Testing Mobile Approach 2 (Aim 2)
Description: Implementation of Antigen and PCR testing at mobile test sites - baseline outreach
Study: NCT00005945

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV
Study: NCT03753360

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Internet-Based Mindfulness Program - Stress Free Now for Healers
Description: Stress Free Now for Healers is an online stress management program developed at Cleveland. It's delivered in 4 components:1Weekly introductions to the concepts and meditation theme are delivered via Web page views or a 5to10-min audio clip2Weekly guided meditations 5-20 min ea.available as embedded/downloadable mp3 on the website or via the Stress Free Now for Healers phone app,which participants are invited to practice at least 4 times each week and to record those practices3Daily articles provide the scientific underpinnings and merits of each week's theme or discuss various cognitive and behavioral strategies,activities,and concepts supporting or related to mindfulness4Daily tips suggesting how to manage stress or incorporate mindfulness in daily activities,including motivational quotes.Participants will have access to a smartphone app with recordings of the 11 guided meditations.Ea. participant will be assigned an e-coach that will communicate with the participant at least weekly.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Active Control Group - Relaxing Music
Description: The control group will be given a flash drive and a link to a website where they can download several digital recordings of relaxing music and will be instructed to quietly listen to one or more of the recordings for at least 5 minutes every day for 6 weeks.
Study: NCT02676648

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multicomponent online program
Description: The core program includes information developed in earlier research with individuals with type 2 diabetes, now modified for online delivery: very low-carbohydrate diet taught with lectures on video, handouts, quizzes, and surveys. We also teach participants about the importance of physical activity and adequate sleep, in addition to psychological skills (positive affect, mindful eating) intending to help with intervention adherence.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multicomponent online program
Description: The core program includes information developed in earlier research with individuals with type 2 diabetes, now modified for online delivery: very low-carbohydrate diet taught with lectures on video, handouts, quizzes, and surveys. We also teach participants about the importance of physical activity and adequate sleep, in addition to psychological skills (positive affect, mindful eating) intending to help with intervention adherence.
Study: NCT00005945

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pegaspargase
Description: Given IM

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thioguanine
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thioguanine
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thioguanine
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thioguanine
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thioguanine
Description: Given PO
Study: NCT02676648

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet-appropriate foods and cookbooks
Description: We will send participants diet-appropriate foods and cookbooks, to support intervention adherence.
Study: NCT00005945

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thioguanine
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Description: Given IV
Study: NCT02676648

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet-appropriate foods and cookbooks
Description: We will send participants diet-appropriate foods and cookbooks, to support intervention adherence.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet-appropriate foods and cookbooks
Description: We will send participants diet-appropriate foods and cookbooks, to support intervention adherence.